Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
10 /100
LOW RISK
Score updated Jul 28, 2026

GH — Guardant Health, Inc. Dilution Risk Tracker

Track GH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GH — Get alerts when the score changes →

As of July 28, 2026, Guardant Health, Inc. (GH) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Guardant Health, Inc. has a market capitalization of $17.20B, 132.60M shares outstanding, 488 institutional holders tracked. Key dilution vectors include 495.8K outstanding warrants, approximately 96 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GH.
🔔 Track GH — Get forecast alerts →

Market Data

Market Cap$17.20B
Shares Outstanding132.60M
Float127.81M
Cash$1.86B
Debt$1.50B
Short InterestN/A

Institutional Holdings

QoQ: ↑ 13.5% shares (2026Q1 vs prior)
488 institutional holders · 157.79M shares
#1 BlackRock, Inc. 11.55M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 11.25M shares
#3 GOLDMAN SACHS GROUP INC 7.06M shares
+ 17 more holders Sign up free to view →

Short Interest

Short Interest11.42M
Days to Cover4.0
% of Float8.9%
FINRA data as of Jul 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-07-07
xbrl XBRL CONVERTIBLE 2025-12-31
4 INSIDER TRANSACTION 2026-04-22
4 INSIDER TRANSACTION 2026-04-20
4 INSIDER TRANSACTION 2026-04-16
Full SEC filing analysis available with free account

Recent News

No recent news

What This Means for GH Shareholders

Guardant Health, Inc. (GH) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 28, 2026.

DilutionWatch tracks 495,775 outstanding warrants for GH. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for GH in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for GH alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →

Understanding GH's Dilution Risk Factors

Primary Risk Drivers

The highest-scoring factors for Guardant Health, Inc. (GH) are Offering Ability, Warrant Exposure, and Convertible Note Risk. These factors indicate potential dilution from future equity offerings or the conversion of existing warrants and notes. Offering Ability suggests the company may have the capacity to issue new shares, which can dilute existing shareholders. Warrant Exposure means that if warrants are exercised, additional shares will be issued, increasing the total share count. Similarly, Convertible Note Risk implies that if outstanding convertible notes are converted into shares, this will also increase the share count and dilute current holders.

Factors Currently Not a Concern

The current low-risk factors include Cash Runway and Float Risk. A Cash Runway score of 0 indicates that GH has sufficient cash reserves (95.7 months remaining) and no immediate liquidity concerns. Float Risk is minimal, suggesting that the number of shares available for trading is not a current threat. However, these factors could become concerning if GH experiences a significant cash burn or if float increases due to new share issuances or conversions.

SEC Filings to Watch

Investors should monitor specific SEC filings for potential dilution signals. An S-3 filing would indicate GH's intent to conduct a public offering, potentially increasing share count. A 424B5 filing is associated with prospectus supplements and may signal additional share issuance. A 8-K Item 1.01 filing would disclose significant events, such as the conversion of convertible notes or the exercise of warrants. A 10-Q filing provides quarterly financial updates and may reveal dilution-related activities.

Key Insight

While GH currently has no immediate dilution risk, future filings and events may significantly alter this profile.

How Dilution Happens

Dilution occurs when new shares are issued or existing convertible instruments are converted. For example, if GH issues new shares through an offering, the total number of shares increases, reducing the ownership percentage of existing shareholders. If warrants are exercised, additional shares are created, further diluting ownership. Similarly, if convertible notes are converted into shares, this also increases the share count, reducing existing holders' equity stake.

What Would Make This Worse

A significant deterioration in GH’s risk profile could occur if multiple dilutive events happen simultaneously. For instance, if GH issues a large equity offering, exercises a large number of warrants, and converts a substantial portion of convertible notes within a short period, this would sharply increase the share count. Such a sequence of events would significantly dilute existing shareholders and increase the overall risk profile of the company.

How to Monitor GH for Dilution Risk

What This Risk Level Means

A DilutionScore of 10/100 indicates that Guardant Health, Inc. (GH) currently has a very low risk of dilution. For a large-cap operating company, this suggests that the company has strong capital structure and is not engaging in dilutive activities such as frequent equity offerings or excessive warrant exercises. Given GH's size and operational maturity, a low DilutionScore implies that the company is likely maintaining a stable share count and is not under pressure to raise capital through equity dilution.

What Typically Happens Next

Companies with low DilutionScores often maintain stable capital structures for extended periods. However, watch for potential dilution triggers such as shelf registrations, ATM programs, or warrant exercises. These events can increase dilution risk, even for large-cap companies. While not common, these actions may occur during periods of financial stress or strategic expansion.

Monitoring Playbook

To monitor GH for dilution risk, use DilutionWatch to set up alerts on key dilution factors. Check the DilutionScore weekly, and set custom thresholds for any changes in dilution risk above 30/100. When thresholds are hit, review the Shelf & ATM Monitor for recent activity. Additionally, monitor SEC filings for any signs of new equity offerings or warrant exercises.

Watch For

Changes in the DilutionScore above 30/100, new shelf registrations, or ATM program activations.

Early Warning Signals

  • A sudden increase in the DilutionScore above 30/100.
  • SEC filings indicating new equity offerings, ATM programs, or warrant exercises.
  • Significant changes in the company’s capital structure, such as large-scale share issuances.

What a Positive Resolution Looks Like

A positive resolution would involve actions that reduce dilution risk, such as the expiration of outstanding warrants, the paydown of debt, or the use of existing capital reserves without issuing new shares. These actions would stabilize or improve the DilutionScore and reduce the risk of future dilution events.

Full SEC filing analysis available with free account  →
Track GH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GH
GH FDA Catalyst Timeline & Biotech Grade — BiotechSignsGH Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.